By using the Gene Expression Profiling Interactive Analysis (GEPIA), an Internet-based tool containing high-throughput RNA-sequencing data (The Cancer Genome Atlas and Genotype-Tissue Expression databases), we found that ACAT1 had high expression in patients suffering from glioma (Figure 1A). This evidence concerns the gene ACAT1 and cancer.